116 related articles for article (PubMed ID: 23516778)
21. Efficacy of duloxetine in painful symptoms: an analgesic or antidepressant effect?
Perahia DG; Pritchett YL; Desaiah D; Raskin J
Int Clin Psychopharmacol; 2006 Nov; 21(6):311-7. PubMed ID: 17012978
[TBL] [Abstract][Full Text] [Related]
22. Safety profile of treatment in diabetic peripheral neuropathic pain.
Robinson-Papp J; Simpson DM
Pain Med; 2007 Sep; 8 Suppl 2():S43-9. PubMed ID: 17714115
[TBL] [Abstract][Full Text] [Related]
23. Clinical comorbidities, treatment patterns, and healthcare costs among patients with fibromyalgia newly prescribed pregabalin or duloxetine in usual care.
Gore M; Tai KS; Chandran A; Zlateva G; Leslie D
J Med Econ; 2012; 15(1):19-31. PubMed ID: 21970699
[TBL] [Abstract][Full Text] [Related]
24. Treatment response to pregabalin in fibromyalgia pain: effect of patient baseline characteristics.
Emir B; Murphy TK; Petersel DL; Whalen E
Expert Opin Pharmacother; 2010 Oct; 11(14):2275-80. PubMed ID: 20812879
[TBL] [Abstract][Full Text] [Related]
25. Cost-effectiveness analysis of pharmacologic treatment of fibromyalgia in Mexico.
Arreola Ornelas H; Rosado Buzzo A; García L; Dorantes Aguilar J; Contreras Hernández I; Mould Quevedo JF
Reumatol Clin; 2012; 8(3):120-7. PubMed ID: 22386298
[TBL] [Abstract][Full Text] [Related]
26. Relationships among pain and depressive and anxiety symptoms in clinical trials of pregabalin in fibromyalgia.
Arnold LM; Leon T; Whalen E; Barrett J
Psychosomatics; 2010; 51(6):489-97. PubMed ID: 21051680
[TBL] [Abstract][Full Text] [Related]
27. [More on therapeutic options in fibromyalgia].
Callejas-Rubio JL; López-Pérez L; Navarro-Pelayo F; Ortego-Centeno N
Med Clin (Barc); 2006 Jun; 127(2):76-7. PubMed ID: 16801007
[No Abstract] [Full Text] [Related]
28. Pregabalin augmentation to antidepressants in patients with major depressive disorder.
Pae CU
Prog Neuropsychopharmacol Biol Psychiatry; 2009 Apr; 33(3):577-8. PubMed ID: 19439242
[No Abstract] [Full Text] [Related]
29. Average daily dose, medication adherence, and healthcare costs among commercially-insured patients with fibromyalgia treated with duloxetine.
Wu N; Chen S; Boulanger L; Rao P; Zhao Y
Curr Med Res Opin; 2011 Jun; 27(6):1131-9. PubMed ID: 21456939
[TBL] [Abstract][Full Text] [Related]
30. [Pregabalin--a neuromodulator for the treatment of neuropathic pain, generalized anxiety disorders and fibromyalgia syndrome].
Nymdelger S; Nieber K
Med Monatsschr Pharm; 2007 Nov; 30(11):396-400. PubMed ID: 18062330
[TBL] [Abstract][Full Text] [Related]
31. Pilot study of duloxetine for cancer patients with neuropathic pain non-responsive to pregabalin.
Matsuoka H; Makimura C; Koyama A; Otsuka M; Okamoto W; Fujisaka Y; Kaneda H; Tsurutani J; Nakagawa K
Anticancer Res; 2012 May; 32(5):1805-9. PubMed ID: 22593465
[TBL] [Abstract][Full Text] [Related]
32. Pregabalin augmentation of quetiapine therapy in the treatment of fibromyalgia: an open-label, prospective trial.
Calandre EP; Morillas-Arques P; Rodriguez-Lopez CM; Rico-Villademoros F; Hidalgo J
Pharmacopsychiatry; 2007 Mar; 40(2):68-71. PubMed ID: 17447176
[TBL] [Abstract][Full Text] [Related]
33. [A new disease understanding of fibromyalgia. A patient with scarred psyche].
Vetter C
MMW Fortschr Med; 2003 Dec; 145(49):20. PubMed ID: 14963988
[No Abstract] [Full Text] [Related]
34. Health outcomes and costs among employees with fibromyalgia treated with pregabalin vs. standard of care.
Kleinman NL; Sanchez RJ; Lynch WD; Cappelleri JC; Beren IA; Joshi AV
Pain Pract; 2011; 11(6):540-51. PubMed ID: 21392253
[TBL] [Abstract][Full Text] [Related]
35. [Unreliable about drug industry].
Mikkelsen Y
Tidsskr Nor Laegeforen; 2010 Jul; 130(13):1331; author reply 1331. PubMed ID: 20596108
[No Abstract] [Full Text] [Related]
36. Potential drug therapies for the treatment of fibromyalgia.
Lawson K
Expert Opin Investig Drugs; 2016 Sep; 25(9):1071-81. PubMed ID: 27269389
[TBL] [Abstract][Full Text] [Related]
37. [Drugs for controversial diseases].
Milerad J
Lakartidningen; 2008 Apr 2-8; 105(14):968. PubMed ID: 18478743
[No Abstract] [Full Text] [Related]
38. Pregabalin in patients with antidepressant treatment-resistant somatoform disorders: a case series.
Harnack D; Scheel M; Mundt A; Kupsch A; Heinz A; Ströhle A
J Clin Psychopharmacol; 2007 Oct; 27(5):537-9. PubMed ID: 17873703
[No Abstract] [Full Text] [Related]
39. [Can we rely on drug industry?].
Slørdal L
Tidsskr Nor Laegeforen; 2010 May; 130(10):1013. PubMed ID: 20489792
[No Abstract] [Full Text] [Related]
40. Efficacy and safety of duloxetine in fibromyalgia.
Ursini F; Pipicelli G; Grembiale RD
Clin Ter; 2010; 161(4):391-5. PubMed ID: 20931165
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
